Quick Answer
MEDIFAST INC reported Gross Profit of $275.19 million for the year ending 2025.
- MEDIFAST INC showed a decrease of -38.1% in Gross Profit from 2024 to 2025.
- This data is from MEDIFAST INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $72.41 million | Q2 2013: $72.93 million | Q3 2013: $64.85 million | Q1 2014: $57.92 million | Q2 2014: $55.57 million | Q3 2014: $50.73 million | Q1 2015: $53.77 million | Q2 2015: $53.17 million | Q3 2015: $49.16 million | Q4 2015: $45.22 million | Q1 2016: $53.19 million | Q2 2016: $53.23 million | Q3 2016: $52.16 million | Q4 2016: $47.08 million | Q1 2017: $52.89 million | Q2 2017: $57.61 million | Q3 2017: $58.18 million | Q4 2017: $59.13 million | Q1 2018: $74.81 million | Q2 2018: $88.80 million | Q3 2018: $107.20 million | Q4 2018: $109.09 million | Q1 2019: $125.15 million | Q2 2019: $140.71 million | Q3 2019: $142.93 million | Q4 2019: $128.07 million | Q1 2020: $135.24 million | Q2 2020: $159.30 million | Q3 2020: $204.04 million | Q4 2020: $199.24 million | Q1 2021: $248.55 million | Q2 2021: $293.71 million | Q3 2021: $307.06 million | Q1 2022: $302.29 million | Q2 2022: $321.68 million | Q3 2022: $282.85 million | Q1 2023: $246.39 million | Q2 2023: $210.72 million | Q3 2023: $177.38 million | Q1 2024: $127.29 million | Q2 2024: $123.44 million | Q3 2024: $105.67 million | Q1 2025: $84.25 million | Q2 2025: $76.64 million | Q3 2025: $62.16 million.
- Over the full 17 years of available data (2009 to 2025), MEDIFAST INC's Gross Profit has grown by 121.2%.
- Historical annual values: Fiscal year 2025: $275.19 million | Fiscal year 2024: $444.62 million | Fiscal year 2023: $775.85 million | Fiscal year 2022: $1.14 billion | Fiscal year 2021: $1.13 billion | Fiscal year 2020: $697.82 million | Fiscal year 2019: $536.86 million | Fiscal year 2018: $379.90 million | Fiscal year 2017: $227.81 million | Fiscal year 2016: $205.66 million | Fiscal year 2015: $201.32 million | Fiscal year 2014: $209.21 million | Fiscal year 2013: $240.57 million | Fiscal year 2012: $235.91 million | Fiscal year 2011: $224.50 million | Fiscal year 2010: $192.47 million | Fiscal year 2009: $124.39 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: